5 Going
Private Event
Beyond agents in the life sciences
Hosted by Gustave Ronteix & 3 others
Registration
Approval Required
Your registration is subject to host approval.
About Event
Agents are all around us, but they still haven’t proven their worth in the life sciences (yet). Join us for breakfast to explore the actual biological validation that will help empower agents for biological research.
As a basis for discussions, we will have three short presentations showcasing this integration at the edge of science : 1) Benchmarking insilico target discovery pipelines, by Gustave Ronteix, CTO of Orakl Oncology, 2) Active learning for antibody-drug conjugate design, by Lilas Germain, CTO of Opsin and 3) Salvaging drug designs from the scientific literature to treat rare diseases, by Mathurin Dorel, CSO of TychoBio
Followed by informal discussions with technical actors of the European life science ecosystems.
5 Going